Clinical Tracking of Cell Transfer and Cell Transplantation: Trials and Tribulations

Jeff W M Bulte1, Heike E Daldrup-Link1

  • 1From the Russell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, Cellular Imaging Section and Vascular Biology Program, Institute for Cell Engineering, Departments of Chemical & Biomolecular Engineering, Biomedical Engineering, and Oncology, The Johns Hopkins University School of Medicine, 217 Traylor Bldg, 720 Rutland Ave, Baltimore, MD 21205 (J.W.M.B.); and Departments of Radiology, Molecular Imaging Program at Stanford (MIPS) and Pediatrics, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, Calif (H.E.D.L.).

Radiology
|October 10, 2018
PubMed

Insights

Clinical cell tracking is advancing, moving beyond proof of concept. Future research must demonstrate how imaging tools improve patient treatment and clinical outcomes for cell therapy.

Area of Science:

  • Regenerative Medicine
  • Oncology
  • Medical Imaging

Background:

  • Cell therapy offers significant potential for tissue repair and cancer treatment.
  • In vivo imaging tools are emerging for tracking therapeutic cells in clinical settings.
  • Current clinical cell tracking studies primarily demonstrate feasibility of cell detection.

Purpose of the Study:

  • To review key clinical questions in cell therapy regarding cell delivery, viability, immune response, differentiation, and proliferation.
  • To assess the current limitations of clinical cell tracking, focusing on immediate delivery and short-term retention.
  • To explore the future clinical relevance and impact of cell tracking technologies on patient management and outcomes.

Main Methods:

  • Review of existing literature on clinical cell tracking studies.
  • Analysis of current clinical queries in cell therapy.
  • Discussion of the transition from proof of principle to clinical utility for cell tracking tools.

Main Results:

  • Clinical cell tracking has confirmed the feasibility of detecting therapeutic cells.
  • Current tracking provides data on immediate cell delivery and short-term retention.
  • Significant questions remain regarding long-term cell fate and therapeutic efficacy.

Conclusions:

  • Cell tracking must evolve beyond feasibility to demonstrate tangible improvements in patient treatment and clinical outcomes.
  • The clinical utility of tracking therapeutic cells requires evidence of impact on patient management and decision-making.
  • Future research should focus on establishing the necessity and benefit of cell tracking for individual patients.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
420
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.0K